Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001787306-24-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | 2024-02-28 | ARQT | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $10.60 | -2,465 | 889.4K | -0.3% | -$26.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | S | D | 2,465 | $10.60 | 889,436 | D | — | — |